dacarbazine,pegfilgrastim,doxorubicin,nivolumab,brentuximab vedotin,vinblastine,filgrastim
amgen,bms,seagen
['hodgkin', 'nivo', 'cml']
very thoughtful and considered discussion on the two hodgkin plenary studies #17icml by peter borchmann. will that amazing hr 0.48 with nivo-avd remain or will some early deeper responders relapse with time? 
Lymphoma doctor, clinical research fellow, wife and mum